Involvement of de NovoCeramide Biosynthesis in Tumor Necrosis Factor-α/Cycloheximide-induced Cerebral Endothelial Cell Death
Open Access
- 1 June 1998
- journal article
- Published by Elsevier BV
- Vol. 273 (26), 16521-16526
- https://doi.org/10.1074/jbc.273.26.16521
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Mechanism of Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) ReductionJournal of Neurochemistry, 1997
- Tumor Necrosis Factor-αStroke, 1997
- Neuroprotective Action of Cycloheximide Involves Induction of Bcl-2 and Antioxidant PathwaysThe Journal of cell biology, 1997
- THE BENEFICIAL EFFECT OF TAURINE ON THE PREVENTION OF HUMAN ENDOTHELIAL CELL DEATHShock, 1996
- A Novel Cytoplasmic Domain of the p55 Tumor Necrosis Factor Receptor Initiates the Neutral Sphingomyelinase PathwayJournal of Biological Chemistry, 1996
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell, 1995
- Ceramide: an endogenous regulator of apoptosis and growth suppresionImmunology Today, 1995
- Receptor-Linked Hydrolysis of Phosphoinositides and Production of Prostacyclin in Cerebral Endothelial CellsJournal of Neurochemistry, 1992
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992
- An update of the enzymology and regulation of sphingomyelin metabolismBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990